Stent vs Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial - A Multicenter Randomized Non-inferiority Clinical Trial of Rectal Indomethacin Alone vs. Indomethacin & Prophylactic Pancreatic Stent Placement for Preventing Post-ERCP Pancreatitis in High-Risk Cases Grant

grant funder

  • NIH

grant sponsor

  • Medical University of South Carolina

date/time interval

  • May 15, 2015 - April 30, 2021

local award ID

  • U01DK104833

contributor